μ receptor and G(i)2α antisense attenuate [D-Met2]-FMRFamide antinociception in mice

Peptides

Volumn 19, Issue 7, 1998, Pages 1171-1175

  Raffa, Robert B ^a   Stone Jr, Dennis J ^b  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

Antinociception; FaRPs; FMRFamide; Mice; Neuropeptide FF; NPFF

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE LIKE PEPTIDE; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE[2 DEXTRO METHIONINE]; UNCLASSIFIED DRUG; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; TAIL FLICK TEST; ANALGESIA; ANIMAL; GENETICS; METABOLISM; PAIN ASSESSMENT; TAIL;

ANALGESIA; ANIMALS; FMRFAMIDE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MALE; MICE; MORPHINE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PAIN MEASUREMENT; RECEPTORS, OPIOID, MU; TAIL;

EID: 0032105498     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00065-5     Document Type: Article

References (43)

1. Adams J.U., Chen X.-H., DeRiel J.K., Yin J., Adler M.W., Liu-Chen L.-Y. Functional effects of antisense oligonucleotides to opioid receptors in rats. Raffa R.B., Porreca F. Antisense strategies for the study of receptor mechanisms. 1996;37-52 R. G. Landes Co, Austin.
2. Allard M., Geoffre S., Legendre P., Vincent J.D., Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res. 500:1989;169-176.
3. Allard M., Jordan D., Zajac J.-M., et al. Autoradiographic localization of receptors for Neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res. 633:1994;127-132.
4. Allard M., Zajac J.-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience. 49:1992;101-111.
5. Chen X.-H., Adams J.U., Geller E.B., DeRiel J.K., Adler M.W., Liu-Chen L.-Y. An antisense oligodeoxynucleotide to μ-opioid receptors inhibits μ-agonist-induced analgesia in rats. Eur. J Pharmacol. 275:1995;105-108.
6. Desprat C., Zajac J.-M. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Dev. Brain Res. 82:1994;118-126.
7. Dockray G.J., Vaillant C., Williams R.G. New vertebrate brain-gut peptide related to a molluscan neuropeptide and an opioid peptide. Nature (London). 293:1981;656-657.
8. Dupouy V., Puget A., Eschalier A., Zajac J.-M. Species differences in the localization of neuropeptide FF receptors in rodent and lagomorph brain and spinal cord. Peptides. 17:1996;399-405.
9. Gicquel S., Fioramonti J., Bueno L., Zajac J.-M. Effects of F8Famide analogs on intestinal transit in mice. Peptides. 14:1993;749-753.
10. Gouardères C., Sutak M., Zajac J.-M., Jhamandes K. Antinociceptive effect of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
11. Greenberg M.J., Painter S.D., Doble K.E., Nagle G.T., Price D.A., Lehman H.K. The molluscan neurosecretory peptide FMRFamide: comparative pharmacology and relationship to the enkephalins. Fed. Proc. 42:1983;82-86.
12. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 1:1957;12-15.
13. 2 (FMRFamide) on morphine-induced inhibition of colonic propulsive motility in mice. Neurosci. Lett. 83:1987;128-132.
14. Janssen P.A.J., Niemegeers C.J.E., Dony J.G.H. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneim. Forsch. 13:1963;502-507.
15. Kivipelto L., Majane E.A., Yang H.-Y. T. Immunohistochemical distribution and partial characterization of FLFQPQRFamide-like peptides in the central nervous system of rats. J. Comp. Neurol. 286:1989;269-287.
16. Kubben F.J.G.M., van Assche C.L.M.V.J., Bosman F.T. FMRF-amide: immunoreactivity in the mammalian gastroenteropancreatic neuroendocrine system. Histochemistry. 84:1986;439-444.
17. 2-like peptides in spinal cords of various mammalian species using radioimmunoassays. Peptides. 9:1988;1137-1144.
18. 2 analogs on intestinal motility and nociception in rats. J. Pharmacol. Exp. Ther. 265:1993;96-102.
19. O'Donohue T.L., Bishop J.F., Chronwell B.M., Groome J., Watson W.H. Characterization and distribution of FMRFamide immunoreactivity in the rat central nervous system. Peptides. 5:1984;563-568.
20. Panula, P.; Kivipelto, L.; Nieminen, O.; Majane, E. A.; Yang, H.-Y. T. Neuroanatomy of morphine-modulating peptides. Med. Biol. 65:127-135; 1993.
21. Price D.A., Greenberg M.J. Structure of a molluscan cardioexcitatory neuropeptide. Science (Washington DC). 197:1977;670-671.
22. Price D.A., Davies N.W., Doble K.E., Greenberg M.J. The variety and distribution of the FMRFamide-related peptides in molluscs. Zool. Sci. 4:1987;395-410.
23. 2) and related peptides on mammals. Peptides. 9:1988;915-922.
24. Raffa R.B. In vivo antisense strategy for the study of second-messengers: application to G-proteins. Raffa R.B., Porreca F. Antisense strategies for the study of receptor mechanisms. 1996;53-69 R. G. Landes Co, Austin.
25. 2), inhibit colonic bead expulsion time in mice. Peptides. 10:1989;873-875.
26. 2-related peptides on mouse colonic propulsive motility a structure-activity relationship study . J. Pharmacol. Exp. Ther. 254:1990;809-814.
27. 2]-FMRF-amide in mice. Neuropeptides. 22:1992;195-203.
28. Raffa, R. B.; Porreca, F. eds. Antisense strategies for the study of receptor mechanisms. Austin: R. G. Landes Co.; 1996.
29. 2]-FMRFamide's mixed action in vivo? Peptides. 17:1996;1261-1265.
30. 2b receptors. Peptides. 15:1994;401-404.
31. Raffa R.B., Martinez R.P., Connelly C.D. G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception. Eur. J. Pharmacol. 258:1994;R5-R7.
32. i2α antisense oligonucleotide differentiates morphine antinociception, constipation and acute dependence in mice. Life Sci./Pharmacol. Lett. 58:1996;L73-L76.
33. 2-adrenoceptor antinociception in mice. Life Sci./Pharmacol Lett. 58:1996;L77-L80.
34. Rossi G.C., Standifer K.M., Pasternak G.W. Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats. Neurosci. Lett. 198:1995;99-102.
35. Rothman R.B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 12:1992;129-138.
36. i2α oligodeoxyribonucleotide antisense antagonism of μ opioid antinociception in mouse tail-immersion test. Analgesia. 1:770-773; 1995.
37. 2-like immunoreactivity. Proc. Natl. Acad. Sci. USA. 81:1984;5002-5005.
38. Wang Z., Lange A.B., Orchard I. Coupling of a single receptor to two different G proteins in the signal transduction of FMRFamide-related peptides. Biochem. Biophys. Res. Commun. 212:1995;531-538.
39. Wang Z., Orchard I., Lange A.B., Chen X., Starratt A.N. A single receptor transduces both inhibitory and stimulatory signals of FMRFamide-related peptides. Peptides. 16:1995;1181-1186.
40. Weber E., Evans C.J., Samuelson S.J., Barchas J.D. Novel peptide neuronal system in rat brain and pituitary. Science (Washington DC). 214:1981;1248-1251.
41. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. USA. 82:1985;7757-7761.
42. Zadina J.E., Kastin A.J. Interactions of Tyr-MIF-1 at opiate receptor sites. Pharmacol. Biochem. Behav. 25:1986;1303-1305.
43. Zhu X.Z., Raffa R.B. Low affinity inhibition of opioid receptor binding by FMRFamide. Neuropeptides. 8:1986;55-61.